NCT06698003 2026-03-05A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1Memorial Sloan Kettering Cancer CenterPhase 2 Recruiting134 enrolled
NCT01626664 2024-04-25KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)Kyowa Kirin Co., Ltd.Phase 2 Completed71 enrolled 15 charts